Loading
Latest filing published 17 Jun 2021 for Acelrx Pharmaceuticals INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Mark G. Edwards is known so far (17 June 2021): a share grant, in Talphera, Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration